CN1051934C - Xiansukang capsule for curing epilepsy and its production - Google Patents
Xiansukang capsule for curing epilepsy and its production Download PDFInfo
- Publication number
- CN1051934C CN1051934C CN95107797A CN95107797A CN1051934C CN 1051934 C CN1051934 C CN 1051934C CN 95107797 A CN95107797 A CN 95107797A CN 95107797 A CN95107797 A CN 95107797A CN 1051934 C CN1051934 C CN 1051934C
- Authority
- CN
- China
- Prior art keywords
- radix
- fine powder
- capsule
- xiansukang
- calculus bovis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese herbal medicine, namely a Xiansukang capsule, for treating epilepsy and a preparation method thereof. The Xiansukang capsule is prepared from 1 wt% of calculus bovis, 1.8 to 2.2 wt% of cinnabar, 14 to 16 wt% of cape jasmine fruit, 11 to 13 wt% of curcuma root, 11 to 13 wt% of baical skullcap root, 9 to 11 wt% of yellow-corktree bark, 9 to 11 wt% of golden thread, 14 to 16 wt% of gentian root and 14 to 16 wt% of rhubarb. Firstly, the cinnabar is refined with water to be prepared into fine powder, and the calculus bovis is ground into fine powder; then other medicines are boiled with water to be prepared into thick paste; the thick paste is uniformly mixed with the cinnabar; the calculus bovis is added after the mixture is dried and milled; then the mixture is sieved and uniformly mixed; and finally, the mixture is encapsulated. The Xiansukang capsule has the advantages of good curative effect, obvious effect, no toxic or side effect, convenient administration and carrying, low price and simple preparation. 158 clinical tests verify that the total effective rate can reach 92.40%, and the Xiansukang capsule is an ideal medicine for treating epilepsy.
Description
The present invention relates to a kind of Chinese medicine for the treatment of epileptics and preparation method thereof.
Epilepsy is a kind of common ictal abnormal mind disease.Primary disease still there is not specific short both at home and abroad at present.Though energy such as Western medicine phenytoin sodium, carbamazepine disease controlling, how undesirable curative effect is, and it is bigger to each system damage of body to take medicine for a long time.And Chinese medicine treatment to primary disease on the basis that dialectical opinion is controlled has certain advantage.
The objective of the invention is: overcome the deficiency of existing medicine and a kind of good effect, instant effect are provided, the medicine valency is low, safety range big, the Chinese medicine of the treatment epileptics of taking convenience and simple preparation method thereof.
The purpose method that the present invention realizes is: Chinese medicine of the present invention is made up of Calculus Bovis, Cinnabaris, Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei, and its weight ratio is 1: 1.8-2.2: 14-16: 11-13: 11-13: 9-11: 9-11: 14-16: 14-16.Preparation method is that Cinnabaris water is flown into fine powder, and Calculus Bovis grinds and is fine powder, and Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei are decocted with water 2 times by proportional quantity; each 1 hour; merging filtrate is concentrated into the thick paste shape, with Cinnabaris fine powder mixing; after 80 ℃ of dryings; be ground into fine powder, become fine powder with the Calculus Bovis facing-up again, (80-100 order) sieves; mixing incapsulates and forms.
Advantage of the present invention is conspicuous, and at first wide with source, the various types of epileptics medicine of treatment by Chinese herbs of the present invention source, the medicine valency is low, and safety range is big, adopts the capsule form taking convenience again, and manufacture method is simple, is applicable to commercial production.Next good effect, instant effect.
The traditional Chinese medical science thinks that " no expectorant is not made epilepsy ", the present invention follow the principle side of the choosing medication of " treat frightened must first eliminating phlegm, eliminating phlegm must relieve dizziness, high fever, infantile convulsions, epilepsy, etc. earlier " just.The Calculus Bovis arresting convulsion that relieves dizziness, high fever, infantile convulsions, epilepsy, etc. in the side, the eliminating phlegm of having one's ideas straightened out is a monarch drug; The Cinnabaris tranquilizing mind, Fructus Gardeniae, the turbid dissipating depression of QI of Radix Curcumaeization, clearing away heart-fire for tranquillization is an accessory drugs; Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae heat clearing and damp drying are adjuvant drug with the source of giving birth to expectorant extremely, behavior messenger drug under the expectorant heat is led in the sedimentation of Radix Et Rhizoma Rhei bitter cold, full side plays clear heat and eliminate phlegm altogether, and the merit of calming heart for resuscitation, suppressing the hyperactive liver to relieve the wind syndrome, tranquillizing the mind by relieving convulsion has significant curative effect to the treatment of epilepsy of " the expectorant heresy is haunted ".The present invention is by Zhengzhou second institute of traditional Chinese medicine clinical verification 158 examples, efficacy evaluation is according to " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " of State Administration of Traditional Chinese Medicine's issue in 1994, proof total effective rate 92.4%, after medication 5-10 days effect appears generally, the course of treatment is the shortest 6 months, and is the longest 2 years, and above clinical people all took phenytoin Sodium before accepting treatment by Chinese herbs of the present invention, anti-insane pain medicine treatment such as carbamazepine, effect is undesirable.
Describe the present invention in detail with embodiment below.
Embodiment 1
Select following prescription for use:
Calculus Bovis 10g Cinnabaris 20g
Fructus Gardeniae 150g Radix Curcumae 120g
Radix Scutellariae 120g Cortex Phellodendri 100g
Rhizoma Coptidis 100g Radix Gentianae 150g
Radix Et Rhizoma Rhei 150g
Earlier Cinnabaris is flown into fine powder by traditional method water, Calculus Bovis grinds and is fine powder, and Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei are decocted with water 2 times by proportioning; each 1 hour, merging filtrate was concentrated into the thick paste shape; again with Cinnabaris fine powder mixing, place 80 ℃ of dryings of dry case after, pulverize and grind to form fine powder; join again and the Calculus Bovis fine powder; sieve (80-100 mesh sieve), mixing, amount incapsulates and forms routinely; each heavy 0.5 gram of capsule contains crude drug in whole 2.5 grams.Oral dose commonly used, each 2-4 grain of being grown up, every day 3 times, the each 1-2 powder of child, every day 2-3 time.
Embodiment 2
Adopt following prescription:
Calculus Bovis 10g Cinnabaris 18g
Fructus Gardeniae 140g Radix Curcumae 110g
Radix Scutellariae 110g Cortex Phellodendri 90g
Rhizoma Coptidis 90g Radix Gentianae 140g
Radix Et Rhizoma Rhei 140g
Earlier Cinnabaris is flown into fine powder by traditional method water, Calculus Bovis grinds and is fine powder, and Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei are decocted with water 2 times by proportioning; each 1 hour, merging filtrate was concentrated into the thick paste shape; again with Cinnabaris fine powder mixing, place 80 ℃ of dryings of dry case after, pulverize and grind to form fine powder; join again and the Calculus Bovis fine powder; sieve (80-100 mesh sieve), mixing, amount incapsulates and forms routinely; each heavy 0.5 gram of capsule contains crude drug in whole 2.5 grams.Oral dose commonly used, each 2-4 grain of being grown up, every day 3 times, the each 1-2 powder of child, every day 2-3 time.
Embodiment 3
Select following prescription for use:
Calculus Bovis 10g Cinnabaris 22g
Fructus Gardeniae 160g Radix Curcumae 130g
Radix Scutellariae 130g Cortex Phellodendri 110g
Rhizoma Coptidis 110g Radix Gentianae 160g
Radix Et Rhizoma Rhei 160g
By the described method preparation of embodiment 1 and take.
In a word, Chinese medicine of the present invention has curative effect preferably to epileptics, and has no side effect, and takes easy to carryly, cheap, be a kind of ideal treatment epilepsy Chinese medicine, and preparation technology is simple, is beneficial to production.
Claims (2)
1, a kind of Chinese medicine for the treatment of epileptics; it is characterized in that by Calculus Bovis, Cinnabaris, Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei being that raw material is made, wherein the weight ratio of each raw material is 1: 18-2.2: 14-16: 11-13: 11-13: 9-11: 9-11: 14-16: 14-16.
2, a kind of preparation method of Chinese medicine of treatment epileptics as claimed in claim 1 is characterized in that Cinnabaris water is flown into fine powder, and Calculus Bovis grinds and is fine powder; Fructus Gardeniae, Radix Curcumae, Radix Scutellariae, Cortex Phellodendri, Rhizoma Coptidis, Radix Gentianae, Radix Et Rhizoma Rhei are decocted with water 2 times by proportional quantity, each 1 hour, merging filtrate; be concentrated into the thick paste shape; with Cinnabaris fine powder mixing, after 80 ℃ of dryings, be ground into fine powder; become fine powder with the Calculus Bovis facing-up again; cross 80-100 sieve, mixing incapsulates and forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95107797A CN1051934C (en) | 1995-07-28 | 1995-07-28 | Xiansukang capsule for curing epilepsy and its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95107797A CN1051934C (en) | 1995-07-28 | 1995-07-28 | Xiansukang capsule for curing epilepsy and its production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1123689A CN1123689A (en) | 1996-06-05 |
| CN1051934C true CN1051934C (en) | 2000-05-03 |
Family
ID=5076443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95107797A Expired - Fee Related CN1051934C (en) | 1995-07-28 | 1995-07-28 | Xiansukang capsule for curing epilepsy and its production |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051934C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063635C (en) * | 1997-12-15 | 2001-03-28 | 房兆亭 | Medicine for curing epilepsy and preparation method thereof |
| CN101134069B (en) * | 2006-08-29 | 2011-08-10 | 金远景 | Capsule for treating hieronosus |
-
1995
- 1995-07-28 CN CN95107797A patent/CN1051934C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《山西中医》1994年第10卷第4期 1994.4.1 郭支露，牛黄三石丸治疗癫痫40例 * |
| 《黑龙江中医药》1987年第5期 1987.5.1 杨占林等，抗痫珍羚丸治疗小儿癫痫24例临床观察 * |
| 《黑龙江中医药》1987年第5期 1987.5.1 杨占林等，抗痫珍羚丸治疗小儿癫痫24例临床观察;《山西中医》1994年第10卷第4期 1994.4.1 郭支露，牛黄三石丸治疗癫痫40例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1123689A (en) | 1996-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20230057438A (en) | Compositions of ginsenosides Rg3 and ginsenosides Rg5 and pharmaceutical uses thereof, including antitumor effects | |
| CN1051934C (en) | Xiansukang capsule for curing epilepsy and its production | |
| CN100350931C (en) | Chinese medicine liniment for treating toothache and its preparing method | |
| CN1058615C (en) | Compound notoginseng preparation | |
| CN1895513A (en) | Medicine for treating oral lichen planus | |
| CN101032612A (en) | Medicine preparation for curing inflammation and tumour and its prepn process | |
| CN1049598C (en) | Chinese medicine prepn for psoriasis and its prepn | |
| CN112957447A (en) | Traditional Chinese medicine composition for treating adenomyosis and preparation method and application of Chinese herbal medicine superfine powder capsule preparation | |
| CN101199822B (en) | Capsule medicament for treating qi blood estrangement vitiligo | |
| CN101904931A (en) | Medicament for treating beriberi and preparation method thereof | |
| CN1081897A (en) | Musk naotongsu | |
| CN1178682C (en) | Angiocardiopathy treating traditional Chinese medicine | |
| CN1063656C (en) | Capsule of peenisetum flaccidum for treating acne and preparing method therefor | |
| CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1261109C (en) | Compound formulation of adjusting, curing or improving blood function | |
| CN103495114A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN102397529B (en) | Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof | |
| CN1977919A (en) | Chinese medicine preparation for treating coronary heart disease angina pectoris and its preparing method | |
| CN1488382A (en) | Health-care medicine for preventing and curing cardio-cerebrovascular diseae | |
| CN1292776C (en) | Medicine for treating facial hemiparalysis disease | |
| CN1259940C (en) | Medicinal composition for treatnig bone fracture | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN103055162A (en) | Medicine for treating coronary heart disease | |
| CN1325721A (en) | Medicine for treating viral diseases | |
| CN104208594A (en) | Pharmaceutical composition for treating vascular tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20000503 Termination date: 20120728 |